Viewing Study NCT04590235

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2026-01-19 @ 11:02 AM
Study NCT ID: NCT04590235
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-08
First Post: 2020-07-28
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neurofibromatosis 1 View
None Neurofibroma Plexiform View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neurofibromatosis Type 1 View
None Plexiform Neurofibromas View
None Phase 1 View
None Selumetinib View
None Chinese View
None Paediatric View
None Adult View